Production and characterization of fusion proteins containing transferrin and nerve growth factor

Journal of Drug Targeting

Volumn 6, Issue 1, 1998, Pages 53-64

  Park, E ^a,c   Starzyk, R M ^a,d   McGrath, J P ^a   Lee, T ^a,e   George, J ^a,f   Schutz, A J ^a,g   Lynch, P ^a,h   Putney, S D ^a,b  

^a ALKERMES INC   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d PFIZER INC   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f BASF Bioresearch Corporation   (United States)

^g GENZYME CORPORATION   (United States)

^h PERKINELMER INC   (United States)

Author keywords

Blood brain barrier; CNS; Nerve growth factor; Transferrin

Indexed keywords

HYBRID PROTEIN; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; TRANSFERRIN; TRANSFERRIN RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DIMERIZATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0031740065     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869808997881     Document Type: Article

References (67)

1. Albeck, D.S., Hoffer, B.J., Quissell, D., Sanders, L.A., Friden, P.M., Zerbe, G. and Granholm, A. A non-invasive transport system for GDNF across the blood brain barrier. Neuro Report (in press).
2. Aruffo, A. and Seed, B. (1987) Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Nat. Acad. Sci. USA, 84, 8573-8577.
3. Backman, C., Rose, G.M., Hoffer, B.J., Henry, M., Bartus, R.T., Friden, P. and Granholm, A.C. (1996) Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy. J. of Neuroscience, 16, 5437-5442.
4. Bailey, S., Evans, R.W., Garratt, R.C., Gorinsky, B., Hasnain, S., Horsburgh, C., Jhoti, H., Lindley, P.F., Mydin, A., Sarra, R. and Watson, J. (1988) Molecular structure of serum transferrin at 3.3-A resolution. Biochemistry, 27, 5804-5812.
5. Banks, W.A., Kastin, A.J., Fasold, M.B., Barrera, C.M. and Augereau, G. (1988) Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier. Brain Res. Bull., 21, 881-885.
6. Barde, Y.A. (1989) Trophic factors and neuronal survival. Neuron, 2, 1525-1534.
7. Baselga, J. and Mendelsohn, J. (1994) Receptor blockade with monoclonal antibodies as anti-cancer therapy. Pharmac. Ther., 64, 127-154.
8. Bebbington, C.R. (1991) Expression of antibody genes in nonlymphoid mammalian cells. Methods: A Companion to Methods in Enzymology, 2, 136-145.
9. Bickel, U., Yoshikawa, T., Landaw, E.M., Faull, K.F. and Pardridge, W.M. (1993) Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc. Natl. Acad. Sci. USA, 90, 2618-2622.
10. Blomer, U., Naldini, L., Verma, I.M., Trono, D. and Gage, F. (1996) Applications of gene therapy to the CNS. Human Molecular Genetics, 5, 1397-1404.
11. Bradshaw, R.A., Murray-Rust, J., Ibanez, C.F., McDonald, N.Q., Lapatto, R. and Blundell, T.L. (1994) Nerve growth factor: structure/function relationships. Protein Science, 3, 1901-1913.
12. Brinkman, U., Buchner, J. and Pastan, I. (1992) Independent domain folding of Pseudomonas exotixin and single-chain immunotoxins: Influence of interdomain connections. Proc. Acad. Natl. Sci. USA, 89, 3075-3079.
13. Broadwell, R.A. and Banks, W.A. (1993). "A cell biological perspective for the transcytosis of peptides and proteins through the mammalian blood brain fluid barriers." The Blood Brain Barrier: Cellular and Molecular Biology, W.A. Pardridge, ed., Raven Press, New York, pp. 165-199.
14. Broadwell, R.D., Balin, B.J. and Salcman, M. (1988) Transcytotic pathway for blood-borne protein through the blood brain barrier. Proc. Natl. Acad. Sci. USA, 85, 632-636.
15. Brock, J.H. (1985). "Transferrins." Metallo Proteins: Part 2: Metal Proteins with Non-redox Roles., P. Harrison, ed., Verlag Chemie, Weinheim, pp. 183-261.
16. Camarata, P.J., Suryanarayanen, R., Turner, D.A., Parker, R.G. and Ebner, T.J. (1992) Sustained release of nerve growth factor from biodegradable polymer microspheres. Neurosurgery, 30, 313-319.
17. Dangl, J.L., Wensel, T.G., Morrison, S.L., Stryer, L., Herzenberg, L.A. and Oi, V.T. (1988) Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J., 7, 1989-1994.
18. Ebendal, T. (1989) NGF in CNS: Experimental data and clinical implications. Progress in Growth Factor Research, 1, 143-159.
19. Fishman, J.B., Rubin, J.B., Handrahan, J.V., Connor, J.R. and Fine, R.F. (1987) Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J. Neurosci. Res., 18, 299-304.
20. Frank, S., Krasznai, K., Durovic, S., Lobentanz, E., Dieplinger, H., Wagner, E., Zatloukal, K., Cotten, M., Utermann, G., Kostner, G. and Zechner, R. (1994) High level expression of various apolipoprotein(a) isoforms by "transferrinfection": The role of kringle IV sequences in the extracellular association with low-density lipoprotein. Biochemistry, 33, 12329-12339.
21. Friden, P.M. (1993). "Receptor-mediated transport of peptides and proteins across the blood-brain barrier." The Blood-Brain Barrier, W.M. Pardridge, ed., Raven Press, Ltd., New York, pp. 229-247.
22. Friden, P.M., Walus, L.R., Musso, G.F., Taylor, M.A., Malfroy, B. and Starzyk, R.M. (1991) Anti-transferrin receptor antibody and antibody drug conjugate cross the blood-brain barrier. Proc. Nat. Acad. Sci. USA, 88, 4771-4775.
23. Friden, P.M., Walus, L.R., Watson, P., Doctrow, S.R., Kozarich, J.W., Backman, C., Bergman, H., Hoffer, B., Bloom, F. and Granholm, A.C. (1993) Blood brain barrier penetration and in vivo activity of an NGF conjugate. Science, 259, 373-377.
24. Granholm, A.C., Backman, C., Bloom, F., Ebendal, T., Gerhardt, G.A., Hoffer, B., Mackerlova, L., Olson, L., Soderstrom, S., Walus, L.R. and Friden, P.M. (1994) NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants. J. Phrmacol. and Exp. Ther., 268, 448-459.
25. Hefti, F., Hartikka, J. and Knusel, B. (1989) Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiology of Aging, 10, 515-533.
26. Hempstead, B.L., Rabin, S.J., Kaplan, L., Reid, S., Parada, L. and Kaplan, D.R. (1992) Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation. Neuron, 9, 883-896.
27. Hopkins, C.R. (1985) Cell, 40, 199-208.
28. Jaenicke, R. (1987) Folding and association of proteins. Prog. Biophys. Mol. Biol., 49, 117-237.
29. Jeffries, W.A., Brandon, M.R., Hunt, S.V., Williams, A.F., Gatter, K.C. and Mason, D.Y. (1984) Transferrin receptor on endothelium of brain capillaries. Nature, 312, 162-163.
30. Kordower, J.H., Charles, V., Bayer, R., Bartus, R.T., Putney, S.D., Walus, L.R. and Friden, P.M. (1994a) Intravenous administration of an antibody-nerve growth factor conjugate prevents degeneration of cholinergic striatal neurons in a model of Huntington's disease. Proc. Natl. Acad. Sci. USA, 91, 9077-9080.
31. Kordower, J.H., Winn, S.R., Liu, Y., Mufson, E.J., Sladek, J.R., Hammang, J.P., Baetge, E.E. and Emerich, D.F. (1994b) The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc. Natl. Acad. Sci. USA, 91, 10898-10902.
32. Kozak, M. (1986) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell, 44, 283-292.
33. Krewson, C.E. and Saltzman, W.M. (1996) Transport and elimination of recombinant human NGF during long-term delivery to the brain. Brain Research, 727, 169-181.
34. Levi-Montalcini, R. (1987) The nerve growth factor 35 years later. Science, 237, 1154-1162.
35. Lindner, M.D., Kearns, C.E., Winn, S.R., Frydel, B. and Emerich, D.F. (1996) Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats. Cell Transpl., 5, 205-223.
36. Maniatis, T., Fritsch, E.F. and Sambrook, J. (1989) Molecular cloning: A Laboratory Manual, Cold Spring Harbor Press, Cold Spring Harbor.
37. Marsh, J.W. and Meville, J.D.M. (1988) A flexible peptide spacer increases the efficacy of holoricin and anti-T cell immunotixins. J. Immunol., 140, 3674-3678.
38. Maysinger, D., Jalsenjak, I. and Cuello, A.C. (1992) Microencapsulated nerve growth factor: effects on the forebrain neurons following devascularizing cortical lesions. 140, 71-74.
39. McDonald, N.Q. and Chao, M.V. (1995) Structural determinants of Neurotrophin action. J. Biol. Chem., 270, 19669-19672.
40. McDonald, N.Q., Lapatto, R., Murray-Rust, J., Gunning, J., Wlodawer, A. and Blundell, T.L. (1991) New protein fold revealed by a 2.3 Å resolution crystal structure of nerve growth factor. Nature, 354, 411-414.
41. McGrath, J.P., Cao, X., Schutz, A., Lynch, P., Ebendal, T., Coloma, M.J., Morrison, S.L. and Putney, S.D. (1997) Bifunctional fusion between nerve growth factor and a transferrin receptor antibody. J. Neurosci. Res., 47, 123-133.
42. Mobley, W.C. (1989) Nerve growth factor in Alzheimer's disease: to treat or not to treat? Nerobiology of Aging, 10, 578-580.
43. Pardridge, W.M. (1991). Peptide Drug Delivery to the Brain, Raven Press, New York.
44. Pardridge, W.M., Boado, R.J. and Kang, Y.-S. (1995a) Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo. Proc. Natl. Acad. Sci. USA, 92, 5592-5596.
45. Pardridge, W.M., Kang, Y.-S. and Buciak, J.L. (1994) Transport of human recombinant brain-derived neutotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector mediated peptide drug delivery. Pharmaceutical Research, 11(5), 738-746.
46. Pardridge, W.M., Kang, Y.-S., Buciak, J.L. and Yange, J. (1995b) Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharmaceutical Research, 12(6), 807-816.
47. Pastan, I. and Fitzgerald, D. (1991) Recombinant toxins for cancer treatment. Science, 254, 1173-1177.
48. Ridet, J.L. and Privat, A. (1995) Gene therapy in the central nervous system: direct versus indirect gene delivery. J. Neurosci. Res., 42, 287-293.
49. Saffran, B.N., Woo, J.E., Mobley, W.C. and Crutcher, K.A. (1989) Intraventricular NGF infusion in the mature rat brain enhances sympathetic innervation of cerebrovascular targets but fails to elicit sympathetic ingrowth. Brain Res., 492, 245-254.
50. Saito, Y., Buciak, J., Yang, J. and Pardridge, W.M. (1995) Vector-mediated delivery of 125-labeled beta-amyloid A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex. Proc. Natl. Acad. Sci. USA, 92, 10227-10231.
51. Shin, S., Friden, P., Moran, M. and Morrison, S.L. (1994) Functional properties of antibody insulin-like growth factor fusion proteins. J. Biol. Chem., 269, 4979-4985.
52. Shin, S. and Morrison, S.L. (1990) Expression and characterization of an antibody binding specificity joined to insulin-like growth factor-I: Potential applications for cellular targeting Proc. Natl. Acad. Sci. USA, 87, 5322-5326.
53. Shin, S.-U., Friden, P., Moran, M., Olson, T., Kang, Y.-S., Pardridge, W. and Morrison, S.L. (1995) Transferrin-antibody fusion proteins are effective in brain targeting. Proc. Natl. Acad. Sci. USA, 92, 2820-2824.
54. 125I] transferrin through the rat blood brain barrier. Brain Research, 683, 164-171.
55. Smith, A.P., Varon, S. and Shooter, E.M. (1968) Multiple forms of the nerve growth factor protein and its subunits. Biochemistry, 7, 3259-3268.
56. Suter, U., Heymach, J.V. and Shooter, E.M. (1991) Two conserved domains in the NGF propeptide arc necessary and sufficient for the biosynthesis of correctly processed and biologically active NGF. EMBO J., 10, 2395-2400.
57. Taylor, E.M., Crowe, A. and Morgan, E.H. (1991) Transferrin and iron uptake by the brain: effects of altered iron status. J. Neurochem., 57, 1584-1592.
58. Thoenen, H., Bandtlow, C. and Heumann, R. (1987) The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev. Physiol. Biochem. Pharmacol., 109, 145-178.
59. Trowbridge, I., Collawn, J. and Hopkins, C.R. (1993) Signal-dependent membrane protein trafficking in the endocytic pathway. Ann. Rev. Cell Biol., 9, 129-161.
60. Turkewitz, A.P., Amatruda, J.F., Borhani, D., Harrison, S.C. and Schwartz, A.L. (1988) A high yield purification of the human transferrin receptor and properties of its major extracellular fragment. J. Biol. Chem., 263, 8318-8325.
61. Ulrich, A., Gray, A., Berman, C. and Dull, T.J. (1983) Human nerve growth factor gene sequence highly homologous to that of mouse. Nature, 303, 821-825.
62. Vinod, C., Mufson, E.J., Friden, P.M., Bartus, R.T. and Kordower, J.H. (1996) Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate. Brain Research, 728, 193-203.
63. Wagner, E., Zatloukal, K., Cotten, M., Kirlappos, H., Mechtler, K., Curiel, D. and Birnstiel, M. (1992) Coupling of adenovirus to transferrin polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci., 89, 6099-6103.
64. Walus, L.R., Pardridge, W.M., Starzyk, R.M. and Friden, P.M. (1996) Enhanced uptake of CD4 across the rodent and primate blood-brain barrier following conjugation to anti-transferrin receptor antibodies. J. Pharmacol. and Exp. Ther., 277, 1067-1075.
65. Watts, C. (1985) J. Cell Biol., 100, 633-637.
66. White, S.R.T., Seligman, P.A., Rutherford, M. and Trowbridge, I.S. (1990) Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: Evidence for synergistic antiproliferative effects. Cancer Res., 50, 6295-6301.
67. Yang, F., Lum, J.B., McGill, J.R., Naylor, S.L., van Bragt, B.H., Baldwin, W.D. and Bowman, B.H. (1984) Human transferrin: cDNA characterization and chromosomal localization. Proc. Nat. Acad. Sci. USA, 81, 2752-2756.